Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Pegfilgrastim Biosimilar (Lunan Pharmaceutical Group Co., Ltd.), Pegylated Human Granulocyte Colony-stimulating Factor (Lunan Pharma), 培非司亭生物类似药 (鲁南制药) + [4] |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (30 Apr 2021), |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Neutropenia | China | 30 Apr 2021 |






